Michael Shih

Michael Shih is a strategic thinker with extensive experience in the corporate world, excelling in biotech and pharmaceutical industries. With a knack for international deal-making and a strong proficiency in managing diverse teams, he boasts a successful track record in navigating complex decision-making structures.

Educationally, Michael holds a B.S. in Molecular Biology from Cornell University, an M.S. in Biology from the University of Illinois at Urbana-Champaign, and a J.D. in Law from Fordham University School of Law.

Throughout his career, Michael has held notable positions including VP of Business Development & Alliance Management at Kite Pharma, SVP & Head of Business Development at Biogen, and leadership roles at Sanofi. His expertise spans various areas such as strategic alliances, mergers, licensing agreements, and corporate development in the pharmaceutical and life sciences sectors.

Michael retired from law and is not involved in sales. His professional history includes roles at renowned organizations like Epizyme, Forest Laboratories, and Eisai US, demonstrating his proficiency in business development and legal affairs.

Michael's specialties encompass a wide range of therapeutic areas including oncology, immunology, neurology, autoimmune diseases, and rare disorders among others. His diverse skill set and international experience make him a valuable asset in strategic decision-making and partnerships within the biotech and pharma industries.